JUNS:Jupiter Neurosciences Inc * Snapshot | Charting | News | Options
*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
$1.65 NASDAQ 3:14p ET
June 30 '25 		Jupiter Neurosciences Showcases Nugevia(TM) PWR: Mitochondrial Optimization Supplement Designed to Boost E... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Jupiter Neurosciences Showcases Nugevia(TM) PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery
     GlobeNewswire
    Full Story →

    Headline News
    Jupiter Neurosciences Unveils Nugevia(TM) GLO: A Breakthrough in Cellular Skin Health, Backed by Patented Pharmaceutical Science
    8:00a ET June 27 '25 GlobeNewswire
    Jupiter Neurosciences Names Golf Legend Annika Sorenstam as First Nugevia(TM) Brand Ambassador
    8:00a ET June 23 '25 GlobeNewswire
    More News →
    Day  38.7%Week  57.1%Month  111%More Charting →
    July 3 '25. Markets Closed.
    Last $1.65
    Day change   38.66%$0.46
    Open $1.22
    Gap at open $0.03
    Previous close $1.19
    Trading volume 4,934,400
    10 Day avg vol. 743,524
    Shares out. 33.1Mil
    Market cap. $54.6Mil
    Trading activity Above Avg.
    Previous data from yesterday, July 2 '25.

    Historical Price Performance
    3 month   201% 
    6 month   80.92% 
    1 year   NA 
    2 year   NA 
    NA = Not Available

    Earnings
    Previous 12m -$0.10
    Next 12m Estimate -$0.25
    P/E ratio --
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2025 All rights reserved.